Transcriptional upregulation of POSTN expression was significantly associated with poor OS rate and DFS rate (P‐value = .001 and .043, respectively, log‐rank test, Figure 6B), indicating that POSTN may serve as a prognostic biomarker for metastatic cervical cancer. This evidence concerns the gene POSTN and cervical carcinoma.